Vicarious Surgical Inc. (RBOT), a company specializing in surgical robotics, faces significant financial challenges, casting doubt on its ability to continue as a going concern. The company reported cash and cash equivalents of $2.6 million and short-term investments of $7.2 million as of December 31, 2025. Due to a reduction in headcount effective March 6, 2026, the company estimates that these funds will be sufficient to support operations through the second quarter of 2026. The company has accumulated a deficit of $246.1 million and has not yet generated any revenue.
For the year ended December 31, 2025, Vicarious Surgical reported a net loss of $50.2 million, compared to a net loss of $63.2 million for the previous year. Research and development expenses decreased by 16% to $33.6 million, while sales and marketing expenses decreased by 52% to $2.2 million. General and administrative expenses also decreased by 31% to $15.2 million. The company attributed these decreases primarily to a reduction in personnel-related expenses and professional fees, reflecting cost control measures and operational efficiencies.
On March 3, 2026, the New York Stock Exchange (NYSE) notified Vicarious Surgical of its decision to immediately suspend trading and commence delisting proceedings for its Class A common stock due to non-compliance with continued listing standards. The company's Class A common stock is now quoted on the OTCID market tier operated by The OTC Markets Group under the symbol "RBOT." This transition to a less liquid market may further depress the trading price of the Class A common stock and negatively impact the company's ability to raise equity financing.
Vicarious Surgical is pursuing a De Novo classification request with the FDA for its Vicarious Surgical System, initially targeting ventral hernia procedures. The company is also working to expand the system's capabilities for additional surgical applications. However, the company has identified a material weakness in its internal control over financial reporting, which could affect the accuracy and timeliness of its financial reporting. The company is taking steps to remediate this weakness, but there is no assurance that these efforts will be successful.
About Vicarious Surgical Inc.
Vicarious Surgical designs and develops advanced robotic systems for minimally invasive surgery, focusing on single-port platforms that enhance dexterity, visualization, and ease of use. Its proprietary technology aims to improve patient outcomes, reduce costs, and expand access to complex procedures. Targeting global markets, the company seeks regulatory approval to commercialize innovative, human-like surgical robots for various abdominal and gynecological surgeries.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.